National Organizations Back New Drug Class for Care of Hypertrophic Cardiomyopathy Patients

National Organizations Back New Drug Class for Care of Hypertrophic Cardiomyopathy Patients

In a big win for heart patients, national guidelines to treat hypertrophic cardiomyopathy now include the first-of-its-kind medication – cardiac myosin inhibitors – as a first-line treatment.

A “MINI” Act Could Be Big for Patients

A “MINI” Act Could Be Big for Patients

Game-changing medical technology is on the line.

Based on Nobel-prize winning science, genetically targeted technologies take on the proteins that cause disease. The medications are administered once or twice a year to treat rare and debilitating diseases, from Duchenne muscular dystrophy to high cholesterol.

Pressure’s Mounting for America’s Hypertension Crisis

Pressure’s Mounting for America’s Hypertension Crisis

Despite the range of existing treatment options, hypertension bears a growing burden on Americans and requires innovative solutions. A new policy paper from the Partnership to Advance Cardiovascular Health, “Pressure’s Mounting,” hears cardiologists, nurses and patient advocates describe the widespread disease’s impact and the importance of individualized treatment. 

Racial Disparities Still Haunt Progress Against CVD

Racial Disparities Still Haunt Progress Against CVD

Cardiovascular disease stubbornly holds its place as the number one cause of death in America. But don’t be misled into thinking heart disease presents an equitable burden. It has a disproportionately high impact on Black Americans, striking them more often and more seriously, on average, than their white counterparts. 

Supporting Employees With Cardiovascular Disease Is A Smart Business Practice

Supporting Employees With Cardiovascular Disease Is A Smart Business Practice

In the United States, cardiovascular disease is a leading cause of death for both men and women. Cardiovascular diseases can manifest through a number of disorders of the heart and blood vessels, such as coronary heart disease, cerebrovascular disease, and deep vein thrombosis.